Early immune biomarkers and intermediate‐term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation‐18

Author:

Stehlik Josef1ORCID,Armstrong Brian2,Baran David A.3ORCID,Bridges Nancy D.4,Chandraker Anil5ORCID,Gordon Robert6,De Marco Teresa7,Givertz Michael M.5,Heroux Alain8,Iklé David2,Hunt Judson9,Kfoury Abdallah G.10,Madsen Joren C.11,Morrison Yvonne4,Feller Erika12,Pinney Sean13,Tripathi Sudipta5,Heeger Peter S.13,Starling Randall C.14

Affiliation:

1. University of Utah School of Medicine Salt Lake City Utah

2. Rho Chapel Hill North Carolina

3. Newark Beth Israel Medical Center Newark New Jersey

4. Transplantation Branch National Institute of Allergy and Infectious Diseases National Institutes of Health Rockville Maryland

5. Brigham and Women's Hospital Boston Massachusetts

6. Northwestern University Chicago Illinois

7. University of California at San Francisco San Francisco California

8. Loyola University Medical Center Maywood Illinois

9. Medical City Dallas Hospital Dallas Texas

10. Intermountain Medical Center Murray Utah

11. Massachusetts General Hospital Boston Massachusetts

12. University of Maryland Baltimore Maryland

13. Icahn School of Medicine at Mount Sinai New York New York

14. Cleveland Clinic Cleveland Ohio

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3